tiprankstipranks
Calidi Biotherapeutics Presents Antitumor Virotherapy Advances
Company Announcements

Calidi Biotherapeutics Presents Antitumor Virotherapy Advances

Don't Miss Our Christmas Offers:

Calidi Biotherapeutics ( (CLDI) ) has shared an announcement.

Calidi Biotherapeutics and its subsidiary Redtail Biopharma showcased their scientific findings on antitumor virotherapies in a webinar with RedChip Companies, an investor relations firm. The presentation, significant for investors monitoring cutting-edge treatments in the biotech sector, can be accessed via the Company’s website. This information, as per regulatory standards, is furnished for transparency but not deemed legally filed or integrated into the Company’s formal filings.

See more data about CLDI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyCalidi files to sell 6.94M shares of common stock for holders
TipRanks Auto-Generated NewsdeskCalidi Biotherapeutics Reveals Promising Virotherapy Data
TheFlyCalidi presents data on RTNova systemic technology in metastatic lung cancer
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App